Thrombosis
Conference Coverage
Nitinol stent maintained patency of hemodialysis access routes
Key clinical point: A covered nitinol stent combined with angioplasty effectively maintained patency in hemodialysis access circuits impaired by...
Conference Coverage
VIDEO: DAPT trials send mixed messages on treatment duration
Conference Coverage
Extended use of oral anticoagulants reduces VTE recurrence
Key clinical point: All of the NOACs provide a net clinical benefit for reducing VTE recurrence. Major finding: The number needed to treat to...
News
Dabigatran raises major bleeding risk
Key clinical point: Dabigatran raises the risk of major bleeding, contrary to initial reports that fast-tracked FDA approval. Major finding:...
News
FDA panel backs edoxaban approval for nonvalvular AF indication
News
Inflammatory rheumatic diseases raise venous thromboembolism risk
Key clinical point: There is strong evidence for an elevated baseline risk of VTE in patients with inflammatory rheumatic diseases. Major finding...
News
New ischemic strokes temper panel’s enthusiasm for Watchman
News
Most acute VTE therapies yield similar outcomes
Key clinical point: Seven of the eight available VTE therapies are equally safe and effective.* Major finding: Compared with standard parenteral...
Conference Coverage
Thrombectomy during primary PCI lacks 1-year benefits
Key clinical point: Thrombus aspiration during primary PCI in acute STEMI patients produced no survival benefit 1 year after treatment in a...
Conference Coverage
VIDEO: Rivaroxaban provides advantages for cardioversion in AF
Conference Coverage
Rivaroxaban shows advantages in AF cardioversion
Key clinical point: Patients in atrial fibrillation were able to safely undergo cardioversion as early as 4 hours after taking their first 20-mg...